Biome Australia Ltd (AU:BIO) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Biome Australia Ltd has successfully identified and validated its new probiotic strain, Lactobacillus plantarum BMB18, marking a significant milestone in its intellectual property ownership and product development efforts. The strain, now registered with the German culture bank DSMZ, is expected to enhance Biome’s competitive edge and create new revenue opportunities. This development positions Biome for potential growth and innovation in the probiotic sector.
For further insights into AU:BIO stock, check out TipRanks’ Stock Analysis page.